It is well known that the distribution of breast cancer intrinsic subtypes (i.e., luminal, HER2-enriched, and triple-negative) varies considerably between Latinas and other population groups [18,19,20,21], suggesting that HER2-low prevalence among Latinas might also differ considerably from what has been reported in other cohorts. Here, ERBB2 is linked to breast cancer.